Indian Biotechnology Market Outlook (2006)

Table of Contents

1. Analyst View

2. Research Overview

3. Biotechnology Industry Overview

• 3.1 Biotechnology Industry - Worldwide
• 3.2 Biotechnology Industry - Asia-Pacific
• 3.3 Biotechnology Industry - India

4. Indian Biotechnology Industry Performance

• 4.1 Market Size
• 4.2 Biotech Domestic and Exports Market
• 4.3 Biotech Market Segmentation
  • 4.3.1 Biopharmaceuticals
  • 4.3.2 BioServices (Contract Research)
  • 4.3.3 Agri Biotech
  • 4.3.4 Industrial Biotech
  • 4.3.5 Bioinformatics
• 4.4 Biotech Parks
  • 4.4.1 Shapoorji Pallonji Biotech Park
  • 4.4.2 ICICI Knowledge Park
  • 4.4.3 International Biotech Park
  • 4.4.4 Lucknow Biotech Park
  • 4.4.5 Ticel Bio Park
  • 4.4.6 Upcoming Parks
• 4.5 Investments in Indian Biotechnology Sector
• 4.6 Employment Opportunities in Biotech Sector
• 4.7 National Biotechnology Development Strategy

5. Indian Bio-Clusters

• 5.1 Southern Region
  • 5.1.1 Andhra Pradesh - The Hyderabad Bio-Cluster
  • 5.1.2 Karnataka - The Bangalore Bio-Cluster
  • 5.1.3 Tamil Nadu - The Chennai Bio-Cluster
  • 5.1.4 Kerala
• 5.2 Western Region
  • 5.2.1 Maharashtra - The Pune Bio-Cluster
  • 5.2.2 Gujarat
• 5.3 Northern Region
  • 5.3.1 Uttar Pradesh - Lucknow
  • 5.3.2 Punjab

6. Industry Analysis

• 6.1 Key Driving Forces
  • 6.1.1 Human Resources
  • 6.1.2 Strong Bio-processing Skills
  • 6.1.3 Bio-diversity
  • 6.1.4 Regulatory Framework
• 6.2 Opportunity
  • 6.2.1 Outsourcing of Preliminary Research
  • 6.2.2 Off-patent Drug
  • 6.2.3 Clinical Trial Opportunity
  • 6.2.4 Bioinformatics
  • 6.2.5 Stem Cell Research
  • 6.2.6 Agricultural Biotechnology
  • 6.2.7 Biofuel
  • 6.2.8 Biofertilizers/BioPesticides
• 6.3 Challenges
  • 6.3.1 Lack of IPR (Intellectual Property Rights) Regime
  • 6.3.2 Time to Market
  • 6.3.3 Seed Funding
  • 6.3.4 Synergy between Stakeholders
  • 6.3.5 High Innovative Drug Cost
  • 6.3.6 Regulatory Issues
• 6.4 Future Outlook, 2010

7. Key Players and Company Profiles

• 7.1 Biotech Suppliers
• 7.2 Biotech Companies
• 7.3 Company Profiles
  • 7.3.1 Biocon
  • 7.3.2 Serum Institute of India
  • 7.3.3 Panacea Biotech
  • 7.3.4 Nicholas Piramal India Limited (NPIL)
  • 7.3.5 Wockhardt Limited
  • 7.3.6 GlaxoSmithKline
  • 7.3.7 Bharat Serums and Vaccines (BSV)
  • 7.3.8 Krebs Biochemical' s & Industries Limited (KBIL)
  • 7.3.9 Zydus Cadila
  • 7.3.10 Indian Immunologicals Limited (IIL)
  • 7.3.11 Shantha Biotechnics
  • 7.3.12 Biological E
  • 7.3.13 Chiron Behring Vaccines
  • 7.3.14 Eli Lilly
  • 7.3.15 Novo Nordisk
  • 7.3.16 Mahyco Monsanto
  • 7.3.17 Bharat Biotech
  • 7.3.18 Abbott
  • 7.3.19 Ranbaxy
  • 7.3.20 Novozymes

8. Annexure I: Government Initiatives and Regulations

• 8.1 Fiscal Incentives Provided to the Biotech Sector
  • 8.1.1 Tax
  • 8.1.2 Regulatory
  • 8.1.3 Investment
• 8.2 Important Changes to the Patents Act in the Third Amendment Bill
  • 8.2.1 Substantive Changes
  • 8.2.2 Procedural Changes
• 8.3 Plant Varieties and Farmers' Rights Protection Act, 2001
• 8.4 Other Regulations impacting the Biotech Sector
  • 8.4.1 Licensing
  • 8.4.2 Clinical Trials
  • 8.4.3 Seeds Act and Policy
  • 8.4.4 Environmental Clearances
  • 8.4.5 Biological Diversity Act

List of Figures:

• Figure 3-1: Worldwide - Biotechnology Market (in Billion US$), 2001-2006E
• Figure 3-2: Worldwide - Biotechnology Market Share by Region (%), 2005
• Figure 3-3: Worldwide - Biotechnology Market Share by Segment (%), 2005
• Figure 3-4: Worldwide - Forecast for Biotechnology Market (in Billion US$), 2007-2010
• Figure 3-5: Asia-Pacific - Biotechnology Market (in Billion US$), 2001-2005
• Figure 3-6: Asia-Pacific - Biotechnology Market Share by Region (%), 2005
• Figure 3-7: Asia-Pacific - Biotechnology Market Share by Segment (%), 2005
• Figure 3-8: Asia-Pacific - Forecast for Biotechnology Market (in Billion US$), 2006-2010
• Figure 3-9: India - Budget Allocations of Major Biotechnology Funding Agencies (in Million US$), 1990-91, 2000-01, 2002-03 to 2004-05
• Figure 4-1: India - Biotechnology Industry Revenue Growth (in Million US$), 2002-03 to 2005-06
• Figure 4-2: India - Market Size of Biotech Industry (in Million US$), 2003-04 to 2005-06
• Figure 4-3: India - Biotechnology Market Share by Segment (%), 2004-05 & 2005-06
• Figure 4-4: India - Domestic Market and Exports Market of Biotech Industry (%), 2005-06
• Figure 4-5: India - Biotech Exports Market Segment (%), 2004-05 & 2005-06
• Figure 4-6: India - Biotech Domestic Market Segment (%), 2004-05 & 2005-06
• Figure 4-7: India - Biotech Domestic Market (in Million US$), 2005-06
• Figure 4-8: India - Bioipharma Segment (%), 2004-05 & 2005-06
• Figure 4-9: India - Revenues from BioPharma (in Million US$), 2004-05 & 2005-06
• Figure 4-10: India - Recombinant Therapeutics Products Market (in Million US$), 2005-06
• Figure 4-11: India - Market Share of BioServices Companies (in Rs Crore), 2005-06
• Figure 4-12: India - Agri Biotech Components' Market (%), 2004-05
• Figure 4-13: India - BT Cotton Seeds Revenues (in Rs Crore), 2003-04 & 2004-05
• Figure 4-14: India - Industrial Biotech Market (in Million US$), 2003-04 to 2005-06
• Figure 4-15: India - Bio-Industrial Companies Revenue (in Million US$), 2003-04 & 2004-05
• Figure 4-16: India - Industrial Biotech Share by Sector (%), 2005-06
• Figure 4-17: India - Growth in Revenue of Major BioIndustrial Firms (%), 2003 to 2005
• Figure 4-18: India - Bioinformatics Market (in Million US$), 2003-04 to 2006-07E
• Figure 4-19: India - Investments in Biotech Industry (in Million US$), 2000-01 to 2005-06
• Figure 4-20: India - Total Manpower in Biotech Sector (in Numbers), 2002-03 to 2004-05
• Figure 4-21: India - Human Resource Allocation in Biotech Sector (%), 2006
• Figure 5-1: India - Revenue of Biotech Industry by Region (%), 2005-06
• Figure 6-1: India - Forecast for Biotechnology Industry (in Billion US$), 2006-2010
• Figure 7-1: India - Revenue of Top 20 Bio-Suppliers by Region (%), 2004-05

List of Tables:

• Table 4-1: India - Segment-wise Exports of Biotech Industry (in Million US$), 2005-06
• Table 4-2: India - BT Cotton Sales (in Packets), 2003-2005
• Table 4-3: India - Permitted BT Cotton Seeds
• Table 7-1: India - Revenue of Top 20 Bio-Suppliers (in Rs Crore), 2003-04 & 2004-05
• Table 7-2: India - Top 20 Biotech Companies by Revenue (in Rs. Crore), 2005-06
• Table 7-3: Top 20 Biotech Companies of Indian Origin by Revenue (in Rs. Crore), 2004-05 & 2005-06
• Table 7-4: Biocon - Key Financials (in Million Rs), 2004-05 & 2005-06
• Table 7-5: Panacea Biotech - Key Financials (in Million Rs), 2004-05 & 2005-06
• Table 7-6: Nicholas Piramal India Limited - Key Financials (in Million Rs), 2004 &2005
• Table 7-7: Wockhardt Limited - Key Financials (in Billion Rs), 2004 & 2005
• Table 7-8: GlaxoSmithKline - Key Financials (in Million US$), 2004 & 2005
• Table 7-9: Krebs Biochemical' s & Industries Limited - Key Financial (in Million US$), 2004-05 & 2005-06
• Table 7-10: Abbott - Key Financial (in Million Rs), May 2006
• Table 7-11: Ranbaxy - Key Financials (in Million Rs), 2005